4//SEC Filing
Dagher Ibrahim B. 4
Accession 0001104659-25-001674
CIK 0001137883other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:11 PM ET
Size
7.6 KB
Accession
0001104659-25-001674
Insider Transaction Report
Form 4
Dagher Ibrahim B.
Chief Medical Officer
Transactions
- Award
Common Stock
2025-01-01+50,000→ 66,849 total
Holdings
- 2,000(indirect: See Note)
Common Stock
- 10,666(indirect: By IRA)
Common Stock
Footnotes (3)
- [F1]Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
- [F2]Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.
- [F3]Represents shares held in a custodial account under the Uniform Transfers to Minors Act for the benefit of the Reporting Person's child. The Reporting Person is the custodian of such account. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Documents
Issuer
BRAINSTORM CELL THERAPEUTICS INC.
CIK 0001137883
Entity typeother
Related Parties
1- filerCIK 0002019599
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:11 PM ET
- Size
- 7.6 KB